Last reviewed · How we verify
Cenobamate Oral Suspension Fed — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Cenobamate Oral Suspension Fed (Cenobamate Oral Suspension Fed) — SK Life Science, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cenobamate Oral Suspension Fed TARGET | Cenobamate Oral Suspension Fed | SK Life Science, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cenobamate Oral Suspension Fed CI watch — RSS
- Cenobamate Oral Suspension Fed CI watch — Atom
- Cenobamate Oral Suspension Fed CI watch — JSON
- Cenobamate Oral Suspension Fed alone — RSS
Cite this brief
Drug Landscape (2026). Cenobamate Oral Suspension Fed — Competitive Intelligence Brief. https://druglandscape.com/ci/cenobamate-oral-suspension-fed. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab